U.S. markets open in 8 hours 45 minutes
  • S&P Futures

    3,834.75
    +25.50 (+0.67%)
     
  • Dow Futures

    31,086.00
    +174.00 (+0.56%)
     
  • Nasdaq Futures

    13,043.25
    +132.25 (+1.02%)
     
  • Russell 2000 Futures

    2,229.80
    +30.60 (+1.39%)
     
  • Crude Oil

    62.48
    +0.98 (+1.59%)
     
  • Gold

    1,747.30
    +18.50 (+1.07%)
     
  • Silver

    26.92
    +0.48 (+1.80%)
     
  • EUR/USD

    1.2086
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    27.95
    -28.89 (-100.00%)
     
  • GBP/USD

    1.3984
    +0.0062 (+0.45%)
     
  • USD/JPY

    106.5540
    +0.0520 (+0.05%)
     
  • BTC-USD

    46,242.03
    +1,216.25 (+2.70%)
     
  • CMC Crypto 200

    924.55
    -8.59 (-0.92%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    29,574.06
    +608.05 (+2.10%)
     

Recap: Tactile Systems Tech Q4 Earnings

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Tactile Systems Tech (NASDAQ:TCMD) fell in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share were up 177.27% over the past year to $0.61, which beat the estimate of $0.24.

Revenue of $59,200,000 higher by 3.74% from the same period last year, which beat the estimate of $58,220,000.

Looking Ahead

Tactile Systems Sees FY21 Sales $215.3M-$224.5M vs $230M Estimate

Details Of The Call

Date: Feb 23, 2021

Time: 05:00 PM

View more earnings on TCMD

ET Webcast URL: https://edge.media-server.com/mmc/p/mp2amvgi

Price Action

Company's 52-week high was at $64.53

52-week low: $29.47

Price action over last quarter: Up 47.38%

Company Overview

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.